J1598 Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg

Short descriptor: Inj glycopyrrolate fres kabi

✓ Active HCPCS Level II 2026
Open J1598 in the app →

Look up J1598 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J1598 is the HCPCS Level II code for Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2025-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
glycopyrrolate, not therapeutically equivalent to j1596
Dose / Unit
0.1 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J1598 with the canonical source and edition:

J1598 — Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J1598

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J1598

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial